MPJE Illinois 4 — Questions and Answers
Question 1: In Illinois, which of the following prescribers is NOT authorized to prescribe Schedule II controlled substances?
- Advanced Practice Registered Nurse with prescriptive authority
- Licensed physician (MD)
- Optometrist holding a therapeutic license (Correct answer)
- Doctor of Osteopathic Medicine (DO)
Correct answer: Optometrist holding a therapeutic license
Illinois optometrists may prescribe certain therapeutic agents but are not authorized to prescribe Schedule II controlled substances.
Question 2: Under Illinois law, which of the following is a valid reason for a pharmacist to refuse to dispense a prescription?
- The prescription is written by an out-of-state licensed prescriber
- The pharmacist believes the prescription is not for a legitimate medical purpose (Correct answer)
- The patient cannot provide a photo ID for a non-controlled prescription
- The prescription was phoned in rather than written
Correct answer: The pharmacist believes the prescription is not for a legitimate medical purpose
A pharmacist has both the right and professional responsibility to refuse dispensing when there is a reasonable belief the prescription lacks a legitimate medical purpose.
Question 3: Illinois law requires pharmacies to report theft or significant loss of controlled substances to the DEA within what timeframe?
- 24 hours by phone and 7 days by DEA Form 106
- 1 business day by email to DEA and IDFPR
- 72 hours by DEA Form 106
- Immediately by phone and 7 days by DEA Form 106 (Correct answer)
Correct answer: Immediately by phone and 7 days by DEA Form 106
Federal law (applicable in Illinois) requires immediate telephone notification to the DEA followed by a written report on DEA Form 106 within 7 days of discovering theft or significant loss.
Question 4: Under the Illinois Pharmacy Practice Act, a pharmacist's license renewal period is how long?
- 1 year
- 2 years (Correct answer)
- 3 years
- 4 years
Correct answer: 2 years
Illinois pharmacist licenses are renewed on a 2-year cycle, with renewal deadlines determined by the IDFPR.
Question 5: In Illinois, which requirement applies to a collaborative pharmacy practice agreement (CPPA)?
- It must be approved by the Illinois State Medical Society before implementation
- It must be filed with and approved by IDFPR before the pharmacist may practice under it
- It requires a written agreement signed by the collaborating physician and pharmacist (Correct answer)
- It is only permitted in hospital or health-system settings
Correct answer: It requires a written agreement signed by the collaborating physician and pharmacist
Illinois law requires a written collaborative pharmacy practice agreement signed by both the collaborating prescriber and the pharmacist.
Question 6: An Illinois pharmacy dispenses a generic drug when the prescriber wrote 'brand medically necessary' on the prescription. Which statement is correct?
- The pharmacist may still substitute a generic if it costs less for the patient
- The pharmacist must dispense the brand as written and may not substitute (Correct answer)
- Generic substitution requires prescriber verbal approval but not written notation
- The pharmacist may substitute a generic and notify the prescriber within 48 hours
Correct answer: The pharmacist must dispense the brand as written and may not substitute
When a prescriber indicates 'brand medically necessary' (or equivalent language) in Illinois, the pharmacist must dispense the brand-name drug and may not substitute a generic.
Question 7: Which entity issues DEA registration to a pharmacy in Illinois for the purpose of handling controlled substances?
- Illinois Department of Financial and Professional Regulation (IDFPR)
- Illinois Department of Public Health (IDPH)
- U.S. Drug Enforcement Administration (DEA) (Correct answer)
- Illinois State Police
Correct answer: U.S. Drug Enforcement Administration (DEA)
DEA registration for handling controlled substances is issued by the federal Drug Enforcement Administration, regardless of state.
In Illinois, which of the following prescribers is NOT authorized to prescribe Schedule II controlled substances?